Detalhe da pesquisa
1.
Pharmacokinetics and Safety of Remdesivir in Pregnant and Non-Pregnant Women with COVID-19: Results from IMPAACT 2032.
J Infect Dis
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38839047
2.
Sofosbuvir-velpatasvir in children 3-17 years old with hepatitis C virus infection.
J Pediatr Gastroenterol Nutr
; 78(6): 1342-1354, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38644678
3.
Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials.
Clin Gastroenterol Hepatol
; 21(1): 90-102.e6, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35074532
4.
Sofosbuvir-velpatasvir-voxilaprevir in adolescents 12 to 17 years old with HCV infection.
Hepatology
; 76(2): 445-455, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35112372
5.
The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.
Gastroenterology
; 160(5): 1608-1619.e13, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33307033
6.
Ledipasvir-sofosbuvir in Adolescents With Chronic Hepatitis C and Hematological Malignancies Undergoing Chemotherapy.
J Pediatr Gastroenterol Nutr
; 74(5): 626-630, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149641
7.
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.
J Hepatol
; 73(1): 26-39, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147362
8.
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials.
Hepatology
; 70(5): 1521-1530, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31271665
9.
Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt.
Gut
; 68(4): 721-728, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29666174
10.
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis.
Clin Gastroenterol Hepatol
; 17(12): 2552-2560.e10, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30779990
11.
Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11.
Hepatology
; 68(6): 2158-2166, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30070726
12.
Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection.
Hepatology
; 66(4): 1102-1110, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28543053
13.
The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection.
Hepatology
; 66(2): 371-378, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27997679
14.
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China.
J Gastroenterol Hepatol
; 33(6): 1168-1176, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29380415
15.
Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection.
Hepatology
; 64(4): 1049-56, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27351341
16.
Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry.
J Hepatol
; 62(5): 1040-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25450208
17.
Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4.
J Hepatol
; 63(3): 581-5, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25937436
18.
Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study.
Pediatrics
; 153(3)2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38332740
19.
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.
Lancet HIV
; 11(5): e300-e308, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621393
20.
Pharmacokinetics, Safety, and Tolerability of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in Healthy Chinese Subjects.
Clin Ther
; 42(3): 448-457, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32115243